Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Flow Cytometry Transcription Template
Document related concepts
Transcript
CLUSTER SPECIFICITY CD2 CD3 CD4 CD8 CD5 CD7 CD10 CD16 CD56 CD19 CD20 CD22 CD23 Surface Kappa Surface Lambda CD38 HLA-DR FMC7 CD11b CD11c CD13 CD14 CD15 CD33 CD34 CD64 CD117 CD56 gated on CD38 CYTOPLASMIC: Cyto Kappa Cyto Lambda CD22 TdT MPO CD34 CYTOPLASMIC GATED ON CD38: Cyto Kappa Cyto Lambda 7AAD Pan-T Pan-T Helper-T Suppressor-T T, B subsets T-ALL Ag. Common ALL (CALLA) Natural Killer Cells Natural Killer Cells Pan-B Pan-B Restricted-B B Cells %GATED CELLS GATE # Activated T/B cells, Blasts Activated T/B cells, Blasts B cells Myelomonocytic Ag Monocytic/HCL Ag Myelomonocytic Ag Monocytic Ag Myeloid Ag Myelomonocytic Ag Progenitor cell Ag Monocytic Ag C-kit Terminal transferase Myeloperoxidase Progenitor cell Ag VIABILITY CPT:88189 Immunophenotyping performed and interpreted at Memorial Hermann Hospital. Some of the tests in this panel were developed and their performance characteristics determined by Memorial Hermann Hospital Laboratory. They have not been cleared or approved by the U. S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. These tests are used for clinical purposes. They should not be regarded as investigational or for research. This laboratory is regulated under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) as qualified to perform highlycomplexity clinical testing.
